FENBLOCK™

FENBLOCK™FENBLOCK™FENBLOCK™

FENBLOCK™

FENBLOCK™FENBLOCK™FENBLOCK™
  • Home
  • Endorsements
  • Press Releases
  • FenBlock In The News
  • NEW BOOK
  • CONTACT
  • Blog
  • More
    • Home
    • Endorsements
    • Press Releases
    • FenBlock In The News
    • NEW BOOK
    • CONTACT
    • Blog
  • Home
  • Endorsements
  • Press Releases
  • FenBlock In The News
  • NEW BOOK
  • CONTACT
  • Blog

FENBLOCK™ A New Approach to Managing Fentanyl Patch Use

FENBLOCK™ A New Approach to Managing Fentanyl Patch UseFENBLOCK™ A New Approach to Managing Fentanyl Patch UseFENBLOCK™ A New Approach to Managing Fentanyl Patch Use

A Patented Fentanyl Patch Blocking Device that Allows Graduated Tapering. 

Learn More

FENBLOCK™ A New Approach to Managing Fentanyl Patch Use

FENBLOCK™ A New Approach to Managing Fentanyl Patch UseFENBLOCK™ A New Approach to Managing Fentanyl Patch UseFENBLOCK™ A New Approach to Managing Fentanyl Patch Use

A Patented Fentanyl Patch Blocking Device that Allows Graduated Tapering. 

Learn More

Innovating for Safer Fentanyl Patch Weaning

Addressing the Challenge:

Hospitals and patients, including those  undergoing cancer treatment, cardiac surgery and severe injury face challenges with managing fentanyl patch dependence. FenBlock™ is our innovative response, designed to assist in carefully monitored tapering. Our goal with FenBlock™ is to support patients in their journey towards reduced dependency, contributing to improved quality of life. This product, currently awaiting FDA approval, represents our commitment to advancing patient care in pain management. 

Contact Us

Understanding Fentanyl Patch Use

Fentanyl patches are widely prescribed, and dependency can be a concern.

While managing this dependency can be challenging, it's important to know that support options are being developed. FenBlock™, our innovative product currently awaiting FDA approval, is designed to offer a new approach in managing fentanyl patch use. 

Informing Healthcare Providers

As we navigate the approval process, we're actively working to inform healthcare professionals about FenBlock™. It's a developing option that, upon approval, may provide a new way for doctors to support their patients in managing fentanyl patch use. 

A Considerate Approach to Dependency

It's important to discuss any concerns about fentanyl use with healthcare providers. FenBlock™ aims to offer a controlled, self-managed approach for those seeking alternatives, pending FDA review and approval. 

FenBlock™: Shaping Future Treatment

Exploring New Solutions

FenBlock™, incorporating cutting-edge technology, is being developed as an approach for managing fentanyl patch dependency. Designed to provide a controlled way to taper use, FenBlock™ aims to serve as an intermediary in the medication process. As we seek FDA approval, we're working to inform healthcare professionals about FenBlock™. In anticipation of its potential availability, we encourage open discussions with doctors about this emerging option and are ready to support with necessary information, once it's approved for use. 

Join the Anticipation for FenBlock™

 As we approach the review phase for FenBlock™, a new approach to managing fentanyl dependency is on the horizon. This product, still pending FDA approval, could offer a promising option in opioid management. Stay tuned for updates on its availability. 

Contact us

FenBlock™: Envisioning a Personalized Path in Fentanyl Management


Neil Brereton Jackson CEO & Founder

Fenblock IN THE NEWS

From Morningline WLNI 105.9 FM

Neil Brereton Jackson joins Mari and Brian on The Morningline Show on WLNI 105.9 FM in Lynchburg, Virginia to talk about what led him to wanting to make a difference in the Fentanyl fight locally and in the country, creating Fenblock and how it works, and more. 

THE OPIOID CRISIS: FENBLOCK'S SOLUTION TO FENTANYL ADDICTION

Discover the remarkable journey of Neil Jackson, a visionary who not only battled cancer but also found himself ensnared in the grip of fentanyl addiction. 


Through years of struggle and resilience, Neil unearthed FENBLOCK, an alternative method offering hope and liberation to those controlled by their fentanyl addiction. 

Hear the untold story behind FENBLOCK and illuminate a path of healing and redemption in the face of adversity. 

Featured Article on: The News & Advance

Forest man invents device to control flow of fentanyl from patches

In 2011, Forest resident and former auditor Neil Jackson was diagnosed with chondrosarcoma — a type of cancer that affects the bones and joints. It is a rare cancer that accounts for about 20% of bone tumors. After undergoing life-threatening surgery and surviving, Jackson, now 73, was in insurmountable pain. He was prescribed morphine and codeine-based drugs including Oxycontin, oxycodone and hydromorphone. “And then I had 100 micrograms of fentanyl transdermal going through my chest every hour,” he said..

Read Full Article

Featured Video on: ABC 13 News WSET

Forest man invents 'FenBlock', a device that blocks flow of fentanyl from patches

FOREST, Va. (WSET) — A Forest man is on a mission to set people free from opioid addiction.
He created a device that allows patients to taper off of their fentanyl medication at their own pace.

73-year-old Neil Jackson lives right here in Forest, but he believes his invention will save millions.

"The mission is to save a life," Jackson said...

Watch Video

NEIL BRERETON JACKSON, CEO & Founder

Inspired by his own experience with stage 4 cancer and fentanyl patch dependency, Neil Brereton Jackson developed FenBlock™. This innovative product, designed for self-managed tapering and currently pending FDA approval, aims to assist patients in their journey away from fentanyl dependence, supporting a return to healthier living.

Linkedin Profile

Stay informed

Sign up to receive updates, news, and more.

Contact Us

Please use the form below to contact us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We would love to hear from you!

FenBlock™ was created with empathy for patients facing similar challenges. As we await FDA approval, our goal is to support individuals in their healthcare journeys with this developing solution. 

FENBLOCK™

Lynchburg, Virginia, United States

434-509-2999 Neil@fenblockmed.com

Hours

Open today

09:00 am – 05:00 pm

PROPRIETARY RIGHTS

All materials, including without limitation, data or information developed

and any ideas, know-how, methodologies, equipment/devices or

processes conceived, developed or used or described by above owner;

Neil B. Jackson, and N Brereton Medical Technologies, L.L.C., including

all USPTO copyrights (c) , trademarks ™ , patents ® , trade secrets and

any other proprietary rights related to owner shall be and remain the

sole, protected, and exclusive property of owner.

  • FenBlock In The News
  • CONTACT
  • Blog

N Brereton Medical Technologies LLC

Copyright © 2023 N Brereton Medical Technologies LLC - All Rights Reserved.

Website by 828 Marketing

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept